Exicure, Inc. (XCUR) Stock Rising in Aftermarket Trading Session
Exicure, Inc. (XCUR), a clinical-stage biotechnology company, has surged 8.86% in aftermarket trading session. As a result, XCUR stock is trading at $0.22 at the time of the writing. On Friday, XCUR closed the day at $0.20 after increasing by 3.32% during the regular trading session. The increase in stock has come amid the investigations […]